Evidence map›Paper›PMID 29211899›Full record

ArticleJournal of Crohn's & colitis2018

Exome Sequencing and Genotyping Identify a Rare Variant in NLRP7 Gene Associated With Ulcerative Colitis.

Alexandros Onoufriadis, Kristina Stone, Antreas Katsiamides, Ariella Amar, Yasmin Omar, Katrina M de Lange, Kirstin Taylor, Jeffrey C Barrett, Richard Pollok, Bu'Hussain Hayee and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of Crohn's & colitis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Host-Viral Interactions in the Pathogenesis of Ulcerative Colitis.International journal of molecular sciences · 2021
    Review
  6. Review
  7. Therapeutic implications of inflammasome in inflammatory bowel disease.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Review
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Alexandros OnoufriadisDepartment of Medical and Molecular Genetics, King's College London, London, UK.
Kristina StoneDepartment of Medical and Molecular Genetics, King's College London, London, UK.
Antreas KatsiamidesDepartment of Medical and Molecular Genetics, King's College London, London, UK.
Ariella AmarDepartment of Medical and Molecular Genetics, King's College London, London, UK.
Yasmin OmarDepartment of Medical and Molecular Genetics, King's College London, London, UK.
Katrina M de LangeWellcome Trust Sanger Institute, Hinxton, Cambridge, UK.
Kirstin TaylorDepartment of Medical and Molecular Genetics, King's College London, London, UK.
Jeffrey C BarrettWellcome Trust Sanger Institute, Hinxton, Cambridge, UK.
Richard PollokDepartment Gastroenterology and Hepatology, St George's University Hospitals NHS Foundation Trust, London, UK.
Bu'Hussain HayeeIBD Service, King's College Hospital NHS Foundation Trust, London, UK.
John C MansfieldInstitute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
Jeremy D SandersonDepartment of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Michael A SimpsonDepartment of Medical and Molecular Genetics, King's College London, London, UK.
Christopher G MathewDepartment of Medical and Molecular Genetics, King's College London, London, UK.
Natalie J PrescottDepartment of Medical and Molecular Genetics, King's College London, London, UK.
King's College London · GBWellcome Sanger Institute · GBGuy's and St Thomas' NHS Foundation Trust · GBKing's College Hospital NHS Foundation Trust · GBNewcastle University · GBSt George’s University Hospitals NHS Foundation Trust · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

BACKGROUND AND

aimsAlthough genome-wide association studies [GWAS] in inflammatory bowel disease [IBD] have identified a large number of common disease susceptibility alleles for both Crohn's disease [CD] and ulcerative colitis [UC], a substantial fraction of IBD heritability remains unexplained, suggesting that rare coding genetic variants may also have a role in pathogenesis. We used high-throughput sequencing in families with multiple cases of IBD, followed by genotyping of cases and controls, to investigate whether rare protein-altering genetic variants are associated with susceptibility to IBD.

methodsWhole-exome sequencing was carried out in 10 families in whom three or more individuals were affected with IBD. A stepwise filtering approach was applied to exome variants, to identify potential causal variants. Follow-up genotyping was performed in 6025 IBD cases [2948 CD; 3077 UC] and 7238 controls.

resultsOur exome variant analysis revealed coding variants in the NLRP7 gene that were present in affected individuals in two distinct families. Genotyping of the two variants, p.S361L and p.R801H, in IBD cases and controls showed that the p.S361L variant was significantly associated with an increased risk of ulcerative colitis [odds ratio 4.79, p = 0.0039] and IBD [odds ratio 3.17, p = 0.037]. A combined analysis of both variants showed suggestive association with an increased risk of IBD [odds ratio 2.77, p = 0.018].

conclusionsThe results suggest that NLRP7 signalling and inflammasome formation may be a significant component in the pathogenesis of IBD.

Indexed as

Adaptor Proteins, Signal TransducingCase-Control StudiesColitis, UlcerativeExome SequencingFemaleGenetic Predisposition to DiseaseGenotypeHigh-Throughput Nucleotide SequencingHumansMalePedigreeTripartite Motif ProteinsUbiquitin-Protein LigasesAdaptor Proteins, Signal TransducingNLRP7 protein, humanTRIM31 protein, humanTripartite Motif ProteinsUbiquitin-Protein Ligases

Identifiers

PMID29211899
PMCPMC6290881
OpenAlexW2950810302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.